A brief history of novel drug discovery technologies (Q44385966)

2 December 2017

1 reference

title

A brief history of novel drug discovery technologies (English)

1 reference

2 December 2017

1 reference

Leland J Gershell

1

1 reference

2 December 2017

Joshua H Atkins

series ordinal

2

1 reference

2 December 2017

publication date

1 April 2003

1 reference

Nature Reviews Drug Discovery

2 December 2017

published in

1 reference

2 December 2017

volume

2

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

321-327

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd1064

2 December 2017

exact match

0 references

cites work

Synthesis of mixed oligodeoxyribonucleotides following the solid phase method.

1 reference

Comprehensive survey of combinatorial library synthesis: 2000.

31 March 2020

1 reference

Toward high-throughput synthesis of complex natural product-like compounds in the genomics and proteomics age.

31 March 2020

1 reference

Toward automated synthesis of oligosaccharides and glycoproteins

31 March 2020

1 reference

How to escape the bottleneck of medicinal chemistry

31 March 2020

1 reference

Targeting signal transduction with large combinatorial collections

31 March 2020

1 reference

Continuous cultures of fused cells secreting antibody of predefined specificity

31 March 2020

1 reference

The impact of genomics on drug discovery

31 March 2020

1 reference

Knockouts model the 100 best-selling drugs--will they model the next 100?

31 March 2020

1 reference

Apoptosis and chemoresistance in transgenic cancer models

31 March 2020

1 reference

Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells

31 March 2020

1 reference

Design and therapeutic application of matrix metalloproteinase inhibitors

31 March 2020

1 reference

Drug-like properties and the causes of poor solubility and poor permeability

31 March 2020

1 reference

The properties of known drugs. 1. Molecular frameworks

31 March 2020

1 reference

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

31 March 2020

1 reference

A gene expression database for the molecular pharmacology of cancer

31 March 2020

1 reference

Protein microarrays: prospects and problems

31 March 2020

1 reference

Better therapeutics through microarrays

31 March 2020

1 reference

ADMET--turning chemicals into drugs

31 March 2020

1 reference

In silico ADME/Tox: the state of the art.

31 March 2020

1 reference

Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR

31 March 2020

1 reference

High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compounds

31 March 2020

1 reference

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

31 March 2020

1 reference

The emerging importance of predictive ADME simulation in drug discovery

31 March 2020

1 reference

HIV integrase, a brief overview from chemistry to therapeutics

31 March 2020

1 reference

Fully automated two-dimensional capillary electrophoresis for high sensitivity protein analysis

31 March 2020

1 reference

Milestones in directed enzyme evolution.

31 March 2020

1 reference

Nucleic acid and polypeptide aptamers: a powerful approach to ligand discovery.

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRD1064

1 reference

2 December 2017

1 reference